Crossmark Global Holdings, Inc. Neurocrine Biosciences Inc Transaction History

Crossmark Global Holdings, Inc.

$5.49 Billion
Q4 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 8,465 shares of NBIX stock, worth $973,644. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,465

Previous 8,487 0.26%

Holding current value

$973,644

Previous $978,000 18.1%

% of portfolio

0.02%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$111.62 - $139.44 $2,455 - $3,067	-22 Reduced 0.26%	8,465 $1.16 Million
Q3 2024 Nov 04, 2024	BUY	$114.58 - $153.15 $137,954 - $184,392	1,204 Added 16.53%	8,487 $978,000
Q2 2024 Jul 29, 2024	SELL	$130.86 - $143.19 $85,975 - $94,075	-657 Reduced 8.27%	7,283 $1 Million
Q1 2024 May 13, 2024	SELL	$130.4 - $143.74 $15,126 - $16,673	-116 Reduced 1.44%	7,940 $1.1 Million
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $52,080 - $65,185	-491 Reduced 5.74%	8,056 $1.06 Million
Q3 2023 Nov 08, 2023	SELL	$94.02 - $117.1 $45,975 - $57,261	-489 Reduced 5.41%	8,547 $977,000
Q2 2023 Jul 31, 2023	SELL	$89.53 - $104.87 $33,931 - $39,745	-379 Reduced 4.03%	9,036 $929,000
Q1 2023 May 12, 2023	BUY	$94.11 - $123.02 $19,951 - $26,080	212 Added 2.3%	9,415 $953,000
Q4 2022 Jan 19, 2023	SELL	$106.72 - $127.06 $8,857 - $10,545	-83 Reduced 0.89%	9,203 $1.1 Million
Q3 2022 Nov 01, 2022	SELL	$92.03 - $107.81 $9,663 - $11,320	-105 Reduced 1.12%	9,286 $986,000
Q2 2022 Jul 29, 2022	SELL	$75.79 - $100.07 $7,579 - $10,007	-100 Reduced 1.05%	9,391 $916,000
Q1 2022 May 11, 2022	SELL	$72.45 - $94.81 $724 - $948	-10 Reduced 0.11%	9,491 $890,000
Q4 2021 Jan 10, 2022	SELL	$79.65 - $106.22 $78,057 - $104,095	-980 Reduced 9.35%	9,501 $809,000
Q3 2021 Oct 21, 2021	BUY	$86.18 - $99.03 $903,252 - $1.04 Million	10,481 New	10,481 $1.01 Million
Q3 2021 Oct 13, 2021	SELL	$86.18 - $99.03 $911,008 - $1.05 Million	-10,571 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$89.43 - $102.27 $945,364 - $1.08 Million	10,571 New	10,571 $1.03 Million
Q4 2018 Jan 31, 2019	SELL	$68.32 - $124.36 $170,526 - $310,402	-2,496 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$98.88 - $125.85 $21,753 - $27,687	-220 Reduced 8.1%	2,496 $307,000
Q2 2018 Jul 31, 2018	SELL	$75.3 - $105.99 $27,861 - $39,216	-370 Reduced 11.99%	2,716 $267,000
Q1 2018 Apr 16, 2018	SELL	$75.88 - $92.43 $80,888 - $98,530	-1,066 Reduced 25.67%	3,086 $256,000
Q4 2017 Feb 05, 2018	SELL	$58.53 - $77.59 $30,084 - $39,881	-514 Reduced 11.02%	4,152 $322,000
Q3 2016 Oct 25, 2017	BUY	N/A	4,666	4,666 $286,000

Others Institutions Holding NBIX

# of Institutions

650

Shares Held

96.2M

Call Options Held

380K

Put Options Held

382K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Neurocrine Biosciences Inc Transaction History